Innoviva INVA
$18.41 +$0.00 (0.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.41 0.00%
Open$18.41
Prev close$18.41
Day range$18.33 – $18.79
Volume1.15M
Market cap$1.31B
P/E (TTM)7.8
Dividend yield–
INVA Stock News
Headlines matching Innoviva or the INVA ticker, most recent first.
- Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $34 Positive
- BTIG Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $42
- Earnings Flash (INVA) Innoviva, Inc. Reports Q2 Revenue $119.6M, Vs. FactSet Est of $111.0M
- Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $34
- H.C. Wainwright Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $46
- BTIG Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $42 Positive
- Goldman Sachs Maintains Innoviva(INVA.US) With Sell Rating, Raises Target Price to $18 Positive
- Analysts Offer Insights on Healthcare Companies: Spectral AI (MDAI), NeOnc Technologies Holdings, Inc. (NTHI) and Innoviva (INVA)
- Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $32
- Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $32 Positive
- Oppenheimer Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $35
- BTIG Initiates Innoviva(INVA.US) With Buy Rating, Announces Target Price $35
- Oppenheimer Maintains Innoviva(INVA.US) With Buy Rating, Cuts Target Price to $34 Negative
- Earnings Flash (INVA) Innoviva, Inc. Reports Q3 Revenue $106.1M, Vs. FactSet Est of $115.3M
- H.C. Wainwright Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $46
No comments yet — be the first to weigh in on INVA.
Sign in to join the discussion.